Hainan Haiyao Co Ltd

SHE:000566 China Drug Manufacturers - Specialty & Generic
Market Cap
$977.81 Million
CN¥7.17 Billion CNY
Market Cap Rank
#8727 Global
#1691 in China
Share Price
CN¥5.53
Change (1 day)
-1.60%
52-Week Range
CN¥4.11 - CN¥8.76
All Time High
CN¥24.36
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective product… Read more

Hainan Haiyao Co Ltd (000566) - Net Assets

Latest net assets as of September 2025: CN¥322.36 Million CNY

Based on the latest financial reports, Hainan Haiyao Co Ltd (000566) has net assets worth CN¥322.36 Million CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.79 Billion) and total liabilities (CN¥5.47 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥322.36 Million
% of Total Assets 5.57%
Annual Growth Rate 11.73%
5-Year Change -85.14%
10-Year Change -76.73%
Growth Volatility 648.75

Hainan Haiyao Co Ltd - Net Assets Trend (1990–2024)

This chart illustrates how Hainan Haiyao Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Hainan Haiyao Co Ltd (1990–2024)

The table below shows the annual net assets of Hainan Haiyao Co Ltd from 1990 to 2024.

Year Net Assets Change
2024-12-31 CN¥590.38 Million -73.17%
2023-12-31 CN¥2.20 Billion -5.85%
2022-12-31 CN¥2.34 Billion -2.00%
2021-12-31 CN¥2.38 Billion -39.95%
2020-12-31 CN¥3.97 Billion -14.23%
2019-12-31 CN¥4.63 Billion -4.04%
2018-12-31 CN¥4.83 Billion -4.96%
2017-12-31 CN¥5.08 Billion -9.82%
2016-12-31 CN¥5.63 Billion +121.95%
2015-12-31 CN¥2.54 Billion +46.75%
2014-12-31 CN¥1.73 Billion +8.73%
2013-12-31 CN¥1.59 Billion +6.72%
2012-12-31 CN¥1.49 Billion +11.81%
2011-12-31 CN¥1.33 Billion +170.88%
2010-12-31 CN¥491.82 Million +10.45%
2009-12-31 CN¥445.29 Million +8.67%
2008-12-31 CN¥409.76 Million +15.76%
2007-12-31 CN¥353.98 Million +11.53%
2006-12-31 CN¥317.39 Million +8.34%
2005-12-31 CN¥292.94 Million +10.39%
2004-12-31 CN¥265.38 Million +3702.51%
2003-12-31 CN¥6.98 Million +105.15%
2002-12-31 CN¥-135.56 Million +45.65%
2001-12-31 CN¥-249.44 Million -219.55%
2000-12-31 CN¥208.64 Million -3.01%
1999-12-31 CN¥215.12 Million -26.99%
1998-12-31 CN¥294.63 Million -23.31%
1997-12-31 CN¥384.18 Million -23.64%
1996-12-31 CN¥503.11 Million +6.66%
1995-12-31 CN¥471.68 Million +1.36%
1994-12-31 CN¥465.35 Million +68.87%
1993-12-31 CN¥275.57 Million +43.90%
1992-12-31 CN¥191.50 Million +494.18%
1991-12-31 CN¥32.23 Million +136.93%
1990-12-31 CN¥13.60 Million --

Equity Component Analysis

This analysis shows how different components contribute to Hainan Haiyao Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 362912600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥1.30 Billion 246.98%
Other Comprehensive Income CN¥217.88 Million 41.48%
Other Components CN¥2.64 Billion 502.42%
Total Equity CN¥525.29 Million 100.00%

Hainan Haiyao Co Ltd Competitors by Market Cap

The table below lists competitors of Hainan Haiyao Co Ltd ranked by their market capitalization.

Company Market Cap
Grand City Properties S.A
PINK:GRNNF
 		$702.33 Million
Hosiden Corporation
F:HOD
 		$702.46 Million
Fujian Guanfu Modern Household Wares Co Ltd
SHE:002102
 		$702.75 Million
Man Wah Holdings Limited
F:AAM
 		$703.07 Million
Baticim Bati Anadolu Cimento Sanayi AS
IS:BTCIM
 		$701.78 Million
Shenzhen Chuangyitong Technology Co.Ltd.
SHE:300991
 		$701.67 Million
Santacruz Silv
V:SCZ
 		$701.67 Million
Revenio Group Oyj
OTCGREY:REVXF
 		$701.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hainan Haiyao Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,062,448,000 to 525,287,000, a change of -1,537,161,000 (-74.5%).
  • Net loss of 1,525,200,915 reduced equity.
  • Dividend payments of 113,548,588 reduced retained earnings.
  • Other comprehensive income decreased equity by 11,960,742.
  • Other factors increased equity by 113,549,245.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-1.53 Billion -290.36%
Dividends Paid CN¥113.55 Million -21.62%
Other Comprehensive Income CN¥-11.96 Million -2.28%
Other Changes CN¥113.55 Million +21.62%
Total Change CN¥- -74.53%

Book Value vs Market Value Analysis

This analysis compares Hainan Haiyao Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.66x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 328.95x to 13.66x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1990-12-31 CN¥0.02 CN¥5.53 x
1991-12-31 CN¥0.04 CN¥5.53 x
1992-12-31 CN¥0.24 CN¥5.53 x
1993-12-31 CN¥0.34 CN¥5.53 x
1994-12-31 CN¥0.58 CN¥5.53 x
1995-12-31 CN¥0.58 CN¥5.53 x
1996-12-31 CN¥0.62 CN¥5.53 x
1997-12-31 CN¥0.47 CN¥5.53 x
1998-12-31 CN¥0.26 CN¥5.53 x
1999-12-31 CN¥0.27 CN¥5.53 x
2000-12-31 CN¥0.02 CN¥5.53 x
2001-12-31 CN¥-0.31 CN¥5.53 x
2002-12-31 CN¥-0.13 CN¥5.53 x
2003-12-31 CN¥0.01 CN¥5.53 x
2004-12-31 CN¥0.23 CN¥5.53 x
2005-12-31 CN¥0.26 CN¥5.53 x
2006-12-31 CN¥0.30 CN¥5.53 x
2007-12-31 CN¥0.29 CN¥5.53 x
2008-12-31 CN¥0.40 CN¥5.53 x
2009-12-31 CN¥0.44 CN¥5.53 x
2010-12-31 CN¥0.42 CN¥5.53 x
2011-12-31 CN¥1.44 CN¥5.53 x
2012-12-31 CN¥1.45 CN¥5.53 x
2013-12-31 CN¥1.50 CN¥5.53 x
2014-12-31 CN¥1.65 CN¥5.53 x
2015-12-31 CN¥2.11 CN¥5.53 x
2016-12-31 CN¥4.62 CN¥5.53 x
2017-12-31 CN¥3.36 CN¥5.53 x
2018-12-31 CN¥3.47 CN¥5.53 x
2019-12-31 CN¥3.36 CN¥5.53 x
2020-12-31 CN¥2.86 CN¥5.53 x
2021-12-31 CN¥1.66 CN¥5.53 x
2022-12-31 CN¥1.67 CN¥5.53 x
2023-12-31 CN¥1.59 CN¥5.53 x
2024-12-31 CN¥0.40 CN¥5.53 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hainan Haiyao Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -290.36%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -153.95%
  • • Asset Turnover: 0.16x
  • • Equity Multiplier: 11.64x
  • Recent ROE (-290.36%) is below the historical average (-10.30%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1990 28.64% 10.24% 0.62x 4.53x CN¥2.54 Million
1991 19.79% 9.11% 0.51x 4.24x CN¥3.16 Million
1992 5.16% 10.24% 0.34x 1.49x CN¥-9.27 Million
1993 17.36% 17.09% 0.48x 2.13x CN¥20.19 Million
1994 13.72% 36.02% 0.22x 1.69x CN¥17.29 Million
1995 7.92% 28.31% 0.16x 1.79x CN¥-9.82 Million
1996 3.34% 9.66% 0.18x 1.89x CN¥-33.53 Million
1997 -22.43% -134.45% 0.07x 2.41x CN¥-124.59 Million
1998 -44.95% -77.91% 0.12x 4.64x CN¥-115.27 Million
1999 -9.43% -14.94% 0.15x 4.25x CN¥-41.81 Million
2000 -413.55% -35.39% 0.20x 58.97x CN¥-63.60 Million
2001 0.00% -135.05% 0.48x 0.00x CN¥-236.16 Million
2002 0.00% 5.81% 0.51x 0.00x CN¥21.48 Million
2003 315.88% 9.15% 0.72x 47.68x CN¥21.35 Million
2004 13.67% 11.08% 0.46x 2.70x CN¥6.71 Million
2005 10.44% 10.34% 0.42x 2.43x CN¥926.04K
2006 10.05% 11.28% 0.39x 2.27x CN¥126.18K
2007 -12.99% -14.03% 0.38x 2.43x CN¥-60.01 Million
2008 13.26% 11.72% 0.53x 2.15x CN¥11.15 Million
2009 16.78% 12.68% 0.61x 2.16x CN¥26.50 Million
2010 7.67% 5.38% 0.57x 2.51x CN¥-10.04 Million
2011 7.99% 14.56% 0.36x 1.54x CN¥-26.36 Million
2012 5.54% 8.13% 0.34x 1.98x CN¥-62.30 Million
2013 6.32% 9.21% 0.29x 2.34x CN¥-54.63 Million
2014 10.01% 12.12% 0.37x 2.26x CN¥187.25K
2015 8.51% 11.88% 0.34x 2.13x CN¥-34.13 Million
2016 3.03% 10.91% 0.16x 1.77x CN¥-378.24 Million
2017 1.78% 4.75% 0.17x 2.17x CN¥-398.77 Million
2018 2.59% 4.84% 0.24x 2.24x CN¥-341.27 Million
2019 -3.57% -6.51% 0.23x 2.42x CN¥-604.98 Million
2020 -15.66% -26.37% 0.21x 2.77x CN¥-950.82 Million
2021 -72.37% -75.54% 0.25x 3.89x CN¥-1.77 Billion
2022 0.49% 0.59% 0.24x 3.40x CN¥-205.97 Million
2023 -5.16% -7.20% 0.20x 3.57x CN¥-312.73 Million
2024 -290.36% -153.95% 0.16x 11.64x CN¥-1.58 Billion

Industry Comparison

This section compares Hainan Haiyao Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,320,658,603
  • Average return on equity (ROE) among peers: 0.81%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Hainan Haiyao Co Ltd (000566) CN¥322.36 Million 28.64% 16.96x $702.18 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million